New York, NY, Jan. 28, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Immunoglobulin Market by Mode of Delivery (Subcutaneous and Intravenous), by Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and Others), and by Product Type (IgA, IgD, IgG, IgE, and IgM): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global  was valued at approximately USD 10.0 billion in 2017 and is expected to generate around USD 16.6 billion by 2024, at a CAGR of around 7.6% between 2018 and 2024.

Immunoglobulins are glycoprotein molecules that are produced by white blood cells (plasma cells). Immunoglobulins, also referred to as antibodies, operate as a perilous portion of the immune response by precisely recognizing and attaching themselves to specific antigens, such as viruses or bacteria, and assisting in their annihilation. The immunoglobulin classes are labeled as immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin E (IgE), immunoglobulin D (IgD), and immunoglobulin M (IgM). The immunomodulatory and anti-inflammatory properties of immunoglobulin play a major role in enhancing its applications. Immunoglobulins are routinely used for treating multiple diseases that lead to immune system dysfunction and humoral immune deficiency.

Browse through 89 Tables & 28 Figures spread over 110 Pages and in-depth TOC on “Global Immunoglobulin Market Size & Growth 2017 Report: By Type, Industry Share, Trends, Analysis and Forecast 2024”.

Request Free Sample Report of Global Immunoglobulin Market Report @

The growing incidences of autoimmune diseases, such as multiple sclerosis, primary humoral immunodeficiency, immune thrombocytopenia purpura (ITP), Kawasaki syndrome, and autoimmune hemolytic anemia, increasing geriatric population worldwide, steep rise in the cases of neurological disorders, and rising hemophilic patient numbers are likely to drive the global immunoglobulin market in the upcoming years. Technological advancements in purification and production methods along with the efforts taken by the government and non-government organizations to create awareness regarding autoimmune diseases are anticipated to further fuel the immunoglobulin market over the estimated timeframe. Nonetheless, strict government guidelines related to immunoglobulin products and several side effects of immunoglobulin use might restrict the global immunoglobulin market on a global scale.

The global immunoglobulin market has been split into a mode of delivery, application, and product type. By mode of delivery, the immunoglobulin market is segmented into subcutaneous and intravenous. Intravenous held almost 80% of the market share in 2017. Subcutaneous is further segmented into 16.5% concentration, 20% concentration, and others. Intravenous is further segmented into 5% concentration, 10% concentration, and others. The application segment includes Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic thrombocytopenic purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and others. Hypogammaglobulinemia segment constitutes the largest market share and is expected to sustain its dominant position over the estimated time period. By product type, this market includes IgA, IgD, IgG, IgE, and IgM.

Download Free Report PDF Brochure:

By region, the global immunoglobulin market includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North American immunoglobulin market is likely to lead over the forecast time period. This can be attributed to the presence of a high number of major players operating in the immunoglobulin market, the existence of big plasma manufacturing units, high acceptance of modern technologies in immunoglobulin, and the region’s well-established healthcare sector. The U.S. is the leading immunoglobulin market by country in North America and is likely to progress at the topmost CAGR over the anticipated timeframe. This growth can be attributed to high per capita healthcare expenditure.

Europe is anticipated to be the second largest immunoglobulin market in the future, owing to the growing geriatric population and increasing number of hemophilic patients. The maximum percentage of people aged 60 or above are in Europe.

Browse the full “Immunoglobulin Market by Mode of Delivery (Subcutaneous and Intravenous), by Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and Others), and by Product Type (IgA, IgD, IgG, IgE, and IgM): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” Report at 

The Asia Pacific market is projected to propagate at a speedy rate over the forecast period. India, China, and Japan are expected to drive the growth of the Asia Pacific immunoglobulin market in the upcoming years. Developments made in the Asia Pacific region are expected to be driven by growing per growing per capita healthcare expenditure, rapid advancement of healthcare infrastructure, and increased focus on research and development.

The Latin American immunoglobulin market is likely to grow significantly over the estimated time period. This can be attributed to the increasing hemophilic patient numbers, high acceptance of immunoglobulin, and growing geriatric population. The Middle Eastern and African region is predicted to record limited growth due to the shortage of skilled healthcare professionals and the absence of advanced healthcare facilities.

Inquire more about this report before purchase @

Some key players of the global immunoglobulin market include ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Grifols S.A., LFB Biomedicaments S.A., Kedrion S.p.A., Sanquin Plasma Products B.V., and Octapharma AG, among others.

Request customized copy of report @

This report segments the global immunoglobulin market into:

Global Immunoglobulin Market: By Mode of Delivery

  • Subcutaneous
    • 16.5% Concentration
    • 20% Concentration
    • Others
  • Intravenous
    • 5% Concentration
    • 10% Concentration
    • Others

Global Immunoglobulin Market: By Application

  • Hypogammaglobulinemia
  • Immunodeficiency Disease
  • Multifocal Motor Neuropathy
  • Guillain-Barre Syndrome
  • Myasthenia Gravis
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Idiopathic Thrombocytopenic Purpura
  • Specific Antibody Deficiency
  • Inflammatory Myopathies
  • Others

Global Immunoglobulin Market: By Product Type

  • IgA
  • IgD
  • IgG
  • IgE
  • IgM

Global Immunoglobulin Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

  • mHealth Apps Market:
  • Prenatal Vitamin Supplements Market:
  • Healthcare Cloud Computing Market:
  • Sterile Injectable Drugs Market:
  • Smart Healthcare Products Market:           

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

<b
<b

Blog: | | |

Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +4
USA/Canada Toll-Free No.
sales

Website:

Blog:

LEAVE A REPLY

Please enter your comment!
Please enter your name here